» Articles » PMID: 33688169

Geniposide from Var. Makino Attenuates Myocardial Injury in Spontaneously Hypertensive Rats Via Regulating Apoptotic and Energy Metabolism Signalling Pathway

Overview
Specialty Pharmacology
Date 2021 Mar 10
PMID 33688169
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hypertension is closely related to myocardial injury. Long-term hypertension can cause myocardial injury. Therefore, it is very important to find drugs to treat myocardial injury caused by hypertension. The aim of present study is to investigate the effects and mechanisms of geniposide on myocardial injuries in spontaneously hypertensive rats (SHR) and H9c2 cells induced by NaCl solution.

Materials And Methods: Male Wistar-Kyoto (WKY) and SHR rats were given different doses of geniposide (25 mg/kg/d or 50 mg/kg/d) or distilled water for three consecutive weeks. Meanwhile, an H9c2 cell line-injury model was established using a solution of 150 µmol/L NaCl for 8 h. The cardiac function and related indexes of rats were detected.

Results: The results showed that geniposide decreased the levels of COI and COIII, which promoted the phosphorylation of AMPK (p-AMPK) and enhanced the energy metabolism pathway. Geniposide improved myocardial apoptosis by regulating apoptotic proteins (p38, BAX and Bcl-2). Finally, heart function was regulated, and the markers of myocardial injury were decreased. Geniposide increased the viability of H9c2 cells treated with the NaCl solution and decreased the rate of apoptosis by regulating the levels of apoptotic proteins. Geniposide could activate energy metabolism signalling pathway (AMPK/SirT1/FOXO1) and reduce H9c2 cell apoptosis.

Conclusion: Our results showed that the mechanisms by which geniposide improves myocardial injury in SHR may be through regulating the energy metabolism signalling pathway (AMPK/SirT1/FOXO1) and improving myocardial apoptosis by regulating apoptotic proteins.

Citing Articles

Geniposide alleviates post-myocardial infarction-induced pyroptosis by modulating the thioredoxin-interacting protein/NLRP3 signaling pathway.

Jiang Y, Su Y, Li C, Jiang W, Wei Y, Chang G Cytojournal. 2025; 21:80.

PMID: 39916997 PMC: 11801652. DOI: 10.25259/Cytojournal_139_2024.


Geniposide for treating atherosclerotic cardiovascular disease: a systematic review on its biological characteristics, pharmacology, pharmacokinetics, and toxicology.

Li D, Li X, Zhang X, Chen J, Wang Z, Yu Z Chin Med. 2024; 19(1):111.

PMID: 39164773 PMC: 11334348. DOI: 10.1186/s13020-024-00981-3.


Comprehensive quality evaluation of different types of Gardeniae Fructus () and based on LC-MS/MS.

Qian H, Hu Y, Wang Z, Ren A, Zhang H, Chu S Front Plant Sci. 2024; 15:1346591.

PMID: 38476680 PMC: 10927785. DOI: 10.3389/fpls.2024.1346591.


The potential of herbal drugs to treat heart failure: The roles of Sirt1/AMPK.

Zhang T, Xu L, Guo X, Tao H, Liu Y, Liu X J Pharm Anal. 2024; 14(2):157-176.

PMID: 38464786 PMC: 10921247. DOI: 10.1016/j.jpha.2023.09.001.


Bioactive Peptides and Exercise Modulate the AMPK/SIRT1/PGC-1α/FOXO3 Pathway as a Therapeutic Approach for Hypertensive Rats.

Ho J, Baskaran R, Wang M, Yang H, Lo Y, Mohammedsaleh Z Pharmaceuticals (Basel). 2022; 15(7).

PMID: 35890118 PMC: 9319799. DOI: 10.3390/ph15070819.


References
1.
Li Y, Wang L, Dong Z, Wang S, Qi L, Cho K . Cardioprotection of salvianolic acid B and ginsenoside Rg1 combination on subacute myocardial infarction and the underlying mechanism. Phytomedicine. 2019; 57:255-261. DOI: 10.1016/j.phymed.2018.12.040. View

2.
Yu L, Duan Y, Zhao Z, He W, Xia M, Zhang Q . Hydroxysafflor Yellow A (HSYA) Improves Learning and Memory in Cerebral Ischemia Reperfusion-Injured Rats via Recovering Synaptic Plasticity in the Hippocampus. Front Cell Neurosci. 2018; 12:371. PMC: 6200869. DOI: 10.3389/fncel.2018.00371. View

3.
Xiaojing C, Yanfang L, Yanqing G, Fangfang C . Thymopentin improves cardiac function in older patients with chronic heart failure. Anatol J Cardiol. 2016; 17(1):24-30. PMC: 5324858. DOI: 10.14744/AnatolJCardiol.2016.6692. View

4.
Han X, Wang C, Li Y, Jin Z, Zhang B, Dong Y . miR-29b in regulating blood pressure and cardiac function in the rat model of hypertension. Exp Ther Med. 2019; 17(5):3361-3366. PMC: 6447776. DOI: 10.3892/etm.2019.7335. View

5.
Venero J, Doyle M, Shah M, Rathi V, Yamrozik J, Williams R . Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high-volume transplant centre. ESC Heart Fail. 2016; 2(4):150-159. PMC: 5034795. DOI: 10.1002/ehf2.12041. View